CA1159367A - Parenteral solvent and a process for the preparation of stable solutions containing same - Google Patents

Parenteral solvent and a process for the preparation of stable solutions containing same

Info

Publication number
CA1159367A
CA1159367A CA000363725A CA363725A CA1159367A CA 1159367 A CA1159367 A CA 1159367A CA 000363725 A CA000363725 A CA 000363725A CA 363725 A CA363725 A CA 363725A CA 1159367 A CA1159367 A CA 1159367A
Authority
CA
Canada
Prior art keywords
hydroxy
formula
solvent
hydrogen
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000363725A
Other languages
English (en)
French (fr)
Inventor
Geza T. Nagy
Gabor Szepesi
Maria Gazdag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of CA1159367A publication Critical patent/CA1159367A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000363725A 1979-11-02 1980-10-31 Parenteral solvent and a process for the preparation of stable solutions containing same Expired CA1159367A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application
HURI-733 1979-11-02

Publications (1)

Publication Number Publication Date
CA1159367A true CA1159367A (en) 1983-12-27

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000363725A Expired CA1159367A (en) 1979-11-02 1980-10-31 Parenteral solvent and a process for the preparation of stable solutions containing same

Country Status (24)

Country Link
US (1) US4344950A (OSRAM)
JP (1) JPS56123911A (OSRAM)
AR (1) AR223735A1 (OSRAM)
AT (1) AT377914B (OSRAM)
AU (1) AU533715B2 (OSRAM)
BE (1) BE885987A (OSRAM)
CA (1) CA1159367A (OSRAM)
CH (1) CH645019A5 (OSRAM)
CS (1) CS226417B2 (OSRAM)
DD (1) DD153760A5 (OSRAM)
DE (1) DE3041368A1 (OSRAM)
DK (1) DK464680A (OSRAM)
FI (1) FI803401L (OSRAM)
FR (1) FR2468373A1 (OSRAM)
GB (1) GB2062464B (OSRAM)
HU (1) HU181940B (OSRAM)
IL (1) IL61310A (OSRAM)
IT (1) IT1209367B (OSRAM)
NL (1) NL8005980A (OSRAM)
NO (1) NO803254L (OSRAM)
PH (1) PH17037A (OSRAM)
SE (1) SE8007569L (OSRAM)
YU (1) YU278880A (OSRAM)
ZA (1) ZA806468B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891B1 (OSRAM) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
CS226417B2 (en) 1984-03-19
IL61310A0 (en) 1980-12-31
GB2062464A (en) 1981-05-28
FR2468373A1 (fr) 1981-05-08
DK464680A (da) 1981-05-03
ZA806468B (en) 1981-10-28
BE885987A (fr) 1981-02-16
FI803401A7 (fi) 1981-05-03
IT8025683A0 (it) 1980-10-31
CH645019A5 (de) 1984-09-14
SE8007569L (sv) 1981-05-03
HU181940B (en) 1983-11-28
JPS56123911A (en) 1981-09-29
IL61310A (en) 1984-08-31
DD153760A5 (de) 1982-02-03
FI803401L (fi) 1981-05-03
PH17037A (en) 1984-05-17
US4344950A (en) 1982-08-17
YU278880A (en) 1984-04-30
AR223735A1 (es) 1981-09-15
FR2468373B1 (OSRAM) 1984-12-28
AT377914B (de) 1985-05-28
GB2062464B (en) 1983-12-07
NL8005980A (nl) 1981-06-01
NO803254L (no) 1981-05-04
ATA527980A (de) 1984-10-15
DE3041368A1 (de) 1981-05-14
AU6400480A (en) 1981-05-07
IT1209367B (it) 1989-07-16
AU533715B2 (en) 1983-12-08

Similar Documents

Publication Publication Date Title
KR100514963B1 (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
JP5453096B2 (ja) （−）−δ９−トランス−テトラヒドロカンナビノールを含んでなる組成物
CA2013167A1 (en) Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
DE69721729D1 (de) [3'-DESOXY-3-OXO-MeBmt]1-[Val]2-CICLOSPORIN ENTHALTENDE ARZNEIMITTELEMULSION
AU635533B2 (en) Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
JPWO1999002158A1 (ja) ４，５−エポキシモルヒナン誘導体を含有する安定な医薬品組成物
CA1159367A (en) Parenteral solvent and a process for the preparation of stable solutions containing same
CZ281142B6 (cs) Roztoky léčiva se zvýšenou stabilitou a bez účinků poškozujících tkáň a způsob jejich přípravy
EP1713466B1 (en) Antiparasitic composition containing an organic amine salt of closantel
CZ69494A3 (en) Sparfloxacine solution, process of its preparation and a sparfloxacine salt
FI95348B (fi) Menetelmä suun kautta annettavan nestemäisen koostumuksen valmistamiseksi
KR910018348A (ko) 술포닐아미노치환 비시클로환계 히드록삼산 유도체
JPH0696533B2 (ja) キノロンカルボン酸の水性組成物
DK154926B (da) Fremgangsmaade til fremstilling af en etomidatholdig infusionsvaeske
JPS61180785A (ja) 新規な治療用組成物
US5561154A (en) Treatment of acute urinary retention
JPS60172929A (ja) 抗健忘症剤
GB1596948A (en) Stable solutions of hydrogenated ergopeptide alkaloids
US6197818B1 (en) Drug for treating diabetic nephrosis
US4518606A (en) Pharmaceutical compositions
US20040106671A1 (en) Remedies for vesical hyperesthesia
US20160317552A1 (en) Pharmaceutical formulations for treating male sexual dysfunctions
JPS632926A (ja) 安定な、注射可能な制吐性組成物
EP0257320A2 (de) Parenterale Lösung
JP2628020B2 (ja) 医薬製剤用水溶液

Legal Events

Date Code Title Description
MKEX Expiry